Integra Lifesciences Holdings Corp. (IART)
NASDAQ:IART
Holding IART?
Track your performance easily

Integra Lifesciences (IART) Ownership - Who Owns Integra Lifesciences?

235 Followers

Integra Lifesciences (IART) Ownership Overview

3.20%32.20%1.84%27.76%35.00%
1.84% Other Institutional Investors
27.76% ETFs
35.00% Public Companies and
Individual Investors
The ownership structure of Integra Lifesciences (IART) stock is a mix of institutional, retail, and individual investors. Approximately 61.80% of the company’s stock is owned by Institutional Investors, 3.20% is owned by Insiders, and 35.00% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Aug 20, 2024
Jeffrey Mosebrook
Svp, Fin & Princ Acct Officer
xxxxxxxxxxxxx
$25690
May 24, 2024
Stuart Essig
Ecob,director
xxxxxxxxxxxxx
$1499742
May 22, 2024
Barbara Hill
Director
xxxxxxxxxxxxx
$995627

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
10,597,526Institution13.73%270,342,888
6,946,181Institution9.00%177,197,077
6,001,503Institution7.78%153,098,342
2,068,912Institution2.68%52,777,945
1,753,434Insider2.27%44,730,101
1,691,400Institution2.19%43,147,614
1,467,632Institution1.90%37,439,292
1,415,207Institution1.83%36,101,931
1,345,807Institution1.74%34,331,537
1,325,532Institution1.72%33,814,321

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
6,001,503Institution7.78%153,098,342
2,068,912Institution2.68%52,777,945
1,691,400Institution2.19%43,147,614
1,415,207Institution1.83%36,101,931
1,345,807Institution1.74%34,331,537
997,492Institution1.29%25,446,021
938,834Institution1.22%23,949,655
796,433Institution1.03%20,317,006
734,979Institution0.95%18,749,314
714,082Institution0.93%18,216,232

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
2,257,075Institution2.93%120,708,371
4,258,778Institution5.52%113,709,373
1,861,586Institution2.41%47,489,059
2,136,253Institution2.77%38,815,717
1,653,071Institution2.14%30,036,300
1,117,736Institution1.45%20,309,263
683,498Institution0.89%18,249,397
990,296Institution1.28%17,993,678
645,962Institution0.84%16,478,491
592,951Institution0.77%15,831,792

FAQ

Who Owns Integra Lifesciences Holdings Corp. (IART)?
According to the latest TipRanks data, approximately 1.84% of the company's stock is held by institutional investors, 3.20% is held by insiders, and 35.00% is held by retail investors.
    What percentage of Integra Lifesciences Holdings Corp. (IART) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 1.84% of Integra Lifesciences Holdings Corp. (IART) stock is held by institutional investors.
      What percentage of Integra Lifesciences Holdings Corp. (IART) stock is held by retail investors?
      According to the latest TipRanks data, approximately 35.00% of Integra Lifesciences Holdings Corp. (IART) stock is held by retail investors.
        Who owns the most shares of Integra Lifesciences Holdings Corp. (IART)?
        iShares owns the most shares of Integra Lifesciences Holdings Corp. (IART).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis